> AstraZeneca on Friday said unspecified export restrictions now rendered plans to bring in large amounts of doses made outside Europe unlikely. It said it now expects to provide 100 million doses to the EU in the first half of this year, down from earlier commitments of around 270 million.
Australia also likely won't be looking to export theirs now, until their whole country is immunized. They are targetting to produce 100 million doses by the end of the year.
All of this over the 3.8 million doses they bought, and were intercepted and taken by Italy (whose export control already reduced the shipment size to 780k doses).